Related Experiment Video
Updated: Aug 1, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Considerations for unblinding individual study participants during vaccine trials
Neal Halsey1, Stephen Evans2, Mathuram Santosham1
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Abstract:
Premature unblinding of individual participants is rarely reported in publications, but such unblinding can disrupt vaccine trials by causing worry and drop-out of other participants or "pseudo unblinding," in which participants or investigators over-interpret certain symptoms as being related to receiving an investigational product. This review summarizes appropriate reasons for unblinding in vaccine trials. Regulatory guidance could be improved by distinguishing guidance for vaccine trials from drug trials, with the recognition that unblinding individual participants in vaccine studies is rarely needed for management of adverse events following immunization.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
Related Concept Videos
Blinding
Blind Procedures
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Ethics in Research
Randomized Experiments
Simple randomization
Simple...
What is an Experiment?